Search results

Page results

• Spread of COVID-19 mapped in hospitals to ‘break the chain’ of transmission

  UCLH will be part of a first-of-its kind clinical trial, led by scientists at UCL, that will evaluate the use of ‘real time’ viral genomic data to reduce the spread of COVID-19 within hospitals.

• Single-dose radiotherapy as effective for treating breast cancer, long-term study finds

  A pioneering breast cancer therapy developed by UCLH and UCL, which requires just one shot of radiotherapy rather than conventional weeks-long treatment, has proven to be as effective for most women in treating the disease.

• SUMMIT Study catches up with pre-pandemic follow up appointments

  As World Lung Cancer Day approaches (1 August) the SUMMIT Study reports that it has made great strides in catching up with patients whose nodule follow ups were cancelled due to COVID-19.

• IUI with donor sperm

  Using donor sperm is on the rise with a statistic showing around 2500 women having treatment with the help of a donor every year. This section outlines some important points surrounding use of donor…

• Legal Parenthood: Information for Patients

  This section applies to couples and single women undergoing treatment with donor sperm.

• Diagnosing acute myeloid leukaemia (AML)

  Acute Myeloid Leukaemia (AML) may be suspected on a simple blood test called a Full Blood Count (FBC) and a blood film that is examined under a microscope.

• Treating acute myeloid leukaemia (AML)

  Your acute myeloid leukaemia (AML) treatment will be delivered within a number of comprehensive specialised services led by medical and nursing cancer care experts.

• Maternity research

  Research is used to build new knowledge, improve current care and develop new treatments. The National Institute for Health Research Clinical Research Network (now referred to as RDN; Research…

• Diagnosing acute lymphoblastic leukaemia (ALL)

  The following tests are used to diagnose ALL.

• Treating acute lymphoblastic leukaemia (ALL)

  Your treatment for acute lymphoblastic leukaemia (ALL) will be delivered within a number of comprehensive specialised services led by medical and nursing cancer care experts.